Open Translation and Analysis Center Authorization Act
Latest action · Aug 4, 2021 Referred to the Subcommittee on Asia, the Pacific, Central Asia and Nonproliferation.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJul 28, 2021
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Open Translation and Analysis Center Authorization Act
This bill establishes the Open Translation and Analysis Center as a federally funded research and development center sponsored by the Department of State.
The center must disseminate translations and analysis of foreign language materials from China and other countries of strategic interest, with a particular focus on government materials (e.g., documents, reports, and speeches of political and military leadership).
To carry out its activities, the center must (1) select appropriate materials for translation and analysis; (2) train analysts and linguists; (3) use technologies to expedite translations; and (4) otherwise coordinate its work with federal agencies, foreign allies, and others. Specifically, the center must cooperate and consult with relevant federal agencies and stakeholders, including grantees of the United States Agency for Global Media and research organizations. The center may consult with foreign governments if the State Department certifies that the consultation serves U.S. national interests.
Additionally, the center must maintain a publicly available website of all translations and analyses that are not subject to copyright or intellectual property protections. Materials subject to those protections must be made available at no cost on a private website to federal employees and contractors and members of Congress and their staff.
The bill designates the State Department as the primary sponsor of the center. However, the State Department may enter into sponsorship agreements with other federal agencies, such as the Central Intelligence Agency.
Cosponsors 6
Members who signed on, in the order they did. Signatures ran from Jul 28, 2021 to Sep 28, 2021, with 4 there on the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-PA | Brian K. Fitzpatrick | Original | Jul 28, 2021 |
| R-WI | Mike Gallagher | Original | Jul 28, 2021 |
| D-MA | William R. Keating | Original | Jul 28, 2021 |
| R-CA | Young Kim | Original | Jul 28, 2021 |
| D-NV | Dina Titus | Sep 28, 2021 | |
| D-CA | Ted Lieu | Sep 28, 2021 |
Actions 3
Everything that happened, newest first.
- Aug 4, 2021Referred to the Subcommittee on Asia, the Pacific, Central Asia and Nonproliferation.
- Jul 28, 2021Introduced in House
- Jul 28, 2021Referred to the House Committee on Foreign Affairs.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 4037 | Pharmaceutical Research Transparency Act of 2022 | Identical bill | Apr 7, 2022 |
Subjects
Assigned by the Library of Congress. Policy area: International Affairs.
Text 1
Each version as it was printed, newest first.
- Jul 28, 2021Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.